THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Pfizer reveals study linking Celebrex to heart risks

By Diedtra Henderson
Globe Staff / February 1, 2005

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size – +

WASHINGTON -- Pfizer Inc. has revealed it completed a study four years ago that links its painkiller Celebrex to a ''statistically significant" increase in heart problems, bolstering demands for speedier dissemination of negative trial results. (Full article: 980 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 article
  • $9.95 4 articles
  • $25.95 Monthly